Truvestments Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9K | Buy |
1,820
+1,065
| +141% | +$40.9K | 0.01% | 338 |
|
|
2025
Q1 | $29.2K | Buy |
755
+130
| +21% | +$5.04K | 0.01% | 489 |
|
|
2024
Q4 | $21.1K | Buy |
625
+199
| +47% | +$6.73K | 0.01% | 492 |
|
|
2024
Q3 | $17.4K | Buy |
+426
| New | +$17.4K | ﹤0.01% | 511 |
|
|
2024
Q2 | – | Sell |
-232
| Closed | -$9.95K | – | 417 |
|
|
2024
Q1 | $9.95K | Hold |
232
| – | – | ﹤0.01% | 500 |
|
|
2023
Q4 | $8.6K | Hold |
232
| – | – | ﹤0.01% | 529 |
|
|
2023
Q3 | $8.41K | Hold |
232
| – | – | ﹤0.01% | 463 |
|
|
2023
Q2 | $8.27K | Sell |
232
-722
| -76% | -$25.7K | ﹤0.01% | 469 |
|
|
2023
Q1 | $33.9K | Buy |
954
+722
| +311% | +$25.7K | 0.02% | 329 |
|
|
2022
Q4 | $8.15K | Buy |
+232
| New | +$8.15K | ﹤0.01% | 486 |
|
|
2022
Q3 | – | Sell |
-393
| Closed | -$21K | – | 639 |
|
|
2022
Q2 | $21K | Buy |
+393
| New | +$21K | 0.01% | 336 |
|
|
2022
Q1 | – | Sell |
-393
| Closed | -$22K | – | 328 |
|
|
2021
Q4 | $22K | Hold |
393
| – | – | 0.01% | 338 |
|
|
2021
Q3 | $19K | Hold |
393
| – | – | 0.01% | 322 |
|
|
2021
Q2 | $20K | Sell |
393
-1,113
| -74% | -$56.6K | 0.01% | 320 |
|
|
2021
Q1 | $68K | Buy |
1,506
+553
| +58% | +$25K | 0.04% | 251 |
|
|
2020
Q4 | $44K | Sell |
953
-688
| -42% | -$31.8K | 0.03% | 279 |
|
|
2020
Q3 | $77K | Sell |
1,641
-213
| -11% | -$10K | 0.07% | 164 |
|
|
2020
Q2 | $94K | Sell |
1,854
-90
| -5% | -$4.56K | 0.1% | 156 |
|
|
2020
Q1 | $92K | Buy |
+1,944
| New | +$92K | 0.12% | 129 |
|
|
2019
Q4 | – | Sell |
-2,428
| Closed | -$130K | – | 320 |
|
|
2019
Q3 | $130K | Sell |
2,428
-60
| -2% | -$3.21K | 0.08% | 162 |
|
|
2019
Q2 | $124K | Sell |
2,488
-729
| -23% | -$36.3K | 0.08% | 165 |
|
|
2019
Q1 | $168K | Buy |
+3,217
| New | +$168K | 0.13% | 119 |
|
|
2018
Q3 | $218K | Buy |
+4,344
| New | +$218K | 0.1% | 170 |
|